R01 CA131183/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2008	6
2009	13
2010	6
2011	6
2012	7
2013	11
2014	3
2016	1
2024	0

1

Ovarian cancer: pathology, biology, and disease models.

Rosen DG, Yang G, Liu G, Mercado-Uribe I, Chang B, Xiao XS, Zheng J, Xue FX, Liu J. Rosen DG, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(6):2089-102. doi: 10.2741/3364. Front Biosci (Landmark Ed). 2009. PMID: 19273186 Free PMC article. Review.

2

Tumor stroma as targets for cancer therapy.

Zhang J, Liu J. Zhang J, et al. Pharmacol Ther. 2013 Feb;137(2):200-15. doi: 10.1016/j.pharmthera.2012.10.003. Epub 2012 Oct 12. Pharmacol Ther. 2013. PMID: 23064233 Free PMC article. Review.

3

Epithelial ovarian cancer: focus on genetics and animal models.

Shan W, Liu J. Shan W, et al. Cell Cycle. 2009 Mar 1;8(5):731-5. doi: 10.4161/cc.8.5.7848. Epub 2009 Mar 14. Cell Cycle. 2009. PMID: 19221485 Review.

4

Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma.

Chen X, Zhang J, Zhang Z, Li H, Cheng W, Liu J. Chen X, et al. Hum Pathol. 2013 Nov;44(11):2373-84. doi: 10.1016/j.humpath.2013.05.001. Epub 2013 Jul 11. Hum Pathol. 2013. PMID: 23850493 Free PMC article. Review.

5

Inflammation: a hidden path to breaking the spell of ovarian cancer.

Shan W, Liu J. Shan W, et al. Cell Cycle. 2009 Oct 1;8(19):3107-11. doi: 10.4161/cc.8.19.9590. Cell Cycle. 2009. PMID: 19738436 Review.

6

The inflammatory network: bridging senescent stroma and epithelial tumorigenesis.

Shan W, Yang G, Liu J. Shan W, et al. Front Biosci (Landmark Ed). 2009 Jan 1;14(11):4044-57. doi: 10.2741/3511. Front Biosci (Landmark Ed). 2009. PMID: 19273333 Free PMC article. Review.

7

CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer.

Chen X, Zhang J, Cheng W, Chang DY, Huang J, Wang X, Jia L, Rosen DG, Zhang W, Yang D, Gershenson DM, Sood AK, Bast RC Jr, Liu J. Chen X, et al. Int J Gynecol Cancer. 2013 Jun;23(5):815-22. doi: 10.1097/IGC.0b013e31828f7a24. Int J Gynecol Cancer. 2013. PMID: 23669443 Free PMC article.

8

Stanniocalcin 1 and ovarian tumorigenesis.

Liu G, Yang G, Chang B, Mercado-Uribe I, Huang M, Zheng J, Bast RC, Lin SH, Liu J. Liu G, et al. J Natl Cancer Inst. 2010 Jun 2;102(11):812-27. doi: 10.1093/jnci/djq127. Epub 2010 May 18. J Natl Cancer Inst. 2010. PMID: 20484106 Free PMC article.

9

AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma.

Yang F, Guo X, Yang G, Rosen DG, Liu J. Yang F, et al. Mod Pathol. 2011 Jun;24(6):836-45. doi: 10.1038/modpathol.2011.44. Epub 2011 Mar 25. Mod Pathol. 2011. PMID: 21441901 Free PMC article.

10

Role of PELP1/MNAR signaling in ovarian tumorigenesis.

Dimple C, Nair SS, Rajhans R, Pitcheswara PR, Liu J, Balasenthil S, Le XF, Burow ME, Auersperg N, Tekmal RR, Broaddus RR, Vadlamudi RK. Dimple C, et al. Cancer Res. 2008 Jun 15;68(12):4902-9. doi: 10.1158/0008-5472.CAN-07-5698. Cancer Res. 2008. PMID: 18559538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year